partial AUCs for locally acting MR [Design Issues]

posted by Kumarnaidu2 – India, 2021-05-28 11:55 (442 d 14:51 ago) – Posting: # 22375
Views: 1,207

Hi all,

Recently we have conducted a pilot BE study of Mesalamine granules 4g. Partial AUCs (AUC0-12 and AUC12-t) were one of the primary parameters as this is for EMA. In this study AUC12-t parameter was not calculated as the concentrations after 12 were BLQ for almost all subjects except one or two subjects. what would be the possible reason for this?

Some solutions suggested by experts include
1) lowering the LLOQ range 2) Increase the dosage (but don't know the highest acceptable dose in healthy volunteer studies).

Any advice and suggestions will be a great help.

Thanks in advance


Complete thread:

UA Flag
 Admin contact
22,301 posts in 4,667 threads, 1,585 registered users;
online 4 (0 registered, 4 guests [including 4 identified bots]).
Forum time: Sunday 02:47 CEST (Europe/Vienna)

No written law has ever been more binding than
unwritten custom supported by popular opinion.    Carrie Chapman Catt

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz